世界のトップ30医薬品製造受託機関(CMO)...市場調査レポートについてご紹介

【英文タイトル】Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Leading Contract Manufacturing Organisations (CMOs) Overview
1.2 Benefits of This Report
1.3 How This Report Delivers Information
1.4 Main Questions This Report Answers
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Related Reports
1.9 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing, 2015
2.1 What Services Do Contract Manufacturers Offer?
2.1.1 Why Do Firms Outsource Manufacturing?
2.1.2 What Is Driving Demand for Contract Manufacturing Services?
2.2 The Pharmaceutical Contract Manufacturing Market, 2014
2.2.1 Where is Supply and Demand Highest for Contract Manufacturing Services?
2.3 Outlook for the Pharmaceutical Contract Manufacturing Market 2015-2025
2.4 Driving and Restrictive Forces for Pharmaceutical Contract Manufacturing, 2015-2025
2.4.1 Pharmaceutical Contract Manufacturing: Market Drivers 2015-2025
2.4.2 Pharmaceutical Contract Manufacturing: Market Restraints 2015-2025
2.5 Who Are the Leading Pharmaceutical Contract Manufacturers in 2014?

3. Leading CMOs in North America
3.1 Catalent Pharma Solutions- One of the World’s Leading CMO
3.1.1 Catalent: Manufacturing Services and Capabilities
3.1.2 Divisional Segmentation – Breaking Down Catalent’s Service
3.1.3 Catalent Pharma’s Revenue Growth, 2010-2014
3.1.4 Sustained Growth in Oral Products: Catalent Pharma’s Divisional Performance, 2010-2014
3.1.5 Catalent Is Expanding its Oral Technologies Division
3.1.6 Quadrupling Biopharmaceutical Manufacturing Capacity
3.1.7 Expansion of Packaging Services in Asia-Pacific and Europe: 2015
3.1.8 Adding New Early-Stage Development Services
3.1.9 Expansion in Japan – Growth Prospects for Catalent
3.1.10 New Business Contracts 2014-2015
3.1.11 Catalent New Products Launch
3.1.12 Catalent: Opportunities for Growth 2015-2025
3.1.13 Catalent: Mild Growth in Revenue, 2015-2025
3.2 Patheon – One of The Top 3 CMOs
3.2.1 Patheon – Global leader in Pharmaceutical Development Services
3.2.2 Contract Manufacturing Services at Patheon
3.2.3 Steady Revenue Growth 2010-2014
3.2.4 DPx Holdings: Developments
3.2.5 Adding New Formulations and Formulation Development Services
3.2.6 Reassessing Manufacturing Capacity
3.2.7 Expanding Services Through Acquisition, 2015
3.2.8 Patheon: SWOT Analysis 2015-2025
3.2.9 Patheon: Contract Manufacturing Revenue Forecast 2015-2025
3.3 Baxter BioPharma Solutions
3.3.1 Baxter BioPharma is the Global Leader in Sterile Fill and Finish
3.3.2 Historic Revenue Performance 2010-2014
3.3.3 Baxter BioPharma SWOT Analysis 2015-2025
3.3.4 Baxter BioPharma Revenue Forecast 2015-2025
3.4 AbbVie Contract Manufacturing
3.4.1 AbbVie Offers Full-Service Contract Manufacturing
3.4.2 Expanding and Adding New Services: 2013-2014
3.4.3 AbbVie Contract Manufacturing: Revenue 2011-2014
3.4.4 Biologics and HPAPIs Are an Opportunity for Growth 2015-2025
3.4.5 AbbVie Contract Manufacturing Revenue Forecast 2015-2025
3.5 Pfizer CentreSource
3.5.1 Pfizer CentreSource: Historic Revenue Performance, 2010-2014
3.5.2 Will Pfizer Divest CentreSource?
3.5.3 Outlook for CentreSource: Revenue Forecast 2015-2025

4. Leading European Contract Manufacturing Organisations
4.1 Lonza
4.1.1 Lonza Is a Leader in Biologics Manufacturing
4.1.2 Lonza Contract Manufacturing and Development: 2010-2014
4.1.3 Investing in Advanced Biological Drug Sectors
4.1.4 The Promise of Antibody-Drug Conjugates (ADCs)
4.1.5 The Regenerative Medicine Future in Japan
4.1.6 Lonza: SWOT Analysis 2015-2025
4.1.7 Biologics and Efficiency Savings Will Drive Growth in Revenue and Operating Profit for Lonza 2015-2025
4.2 Evonik Degussa
4.2.1 Investing in API and Drug Delivery Services
4.2.2 Moderate Growth in Pharmaceutical Manufacturing Services, 2010-2014
4.2.3 Evonik Is a HPAPI Specialist
4.2.4 Evonik Continues to Grow Across All Segments
4.2.5 How Can Evonik Expand in the Pharmaceutical Contract Manufacturing Market?
4.2.6 Evonik Degussa: Revenue Forecast 2015-2025
4.3 Royal DSM – The World’s Leading CMO
4.3.1 Amplified Revenue Growth in Pharma Manufacturing 2010-2014
4.3.2 DSM Pharmaceuticals Products: Manufacturing Services 2010-2014
4.3.3 DSM Sinochem Pharmaceuticals: A World Leader in Antibacterial Manufacturing
4.3.4 DPx Holdings: A New Pharma Leader
4.3.5 Investing in Biopharma Manufacturing
4.3.6 Expanding API Manufacturing
4.3.7 Generics and Biologics Are an Opportunity for Growth, 2014-2025
4.3.8 DSM Pharmaceuticals Products: Revenue Forecast 2015-2025
4.4 Boehringer Ingelheim Contract Manufacturing
4.4.1 Expanding Biopharmaceuticals Manufacturing Services in China
4.4.2 Production Through to Fill and Finished Biopharmaceuticals
4.4.3 A Track Record of Production for 29 Biopharma Products
4.4.4 Increasing Revenue from Contract Manufacturing, 2010-2014
4.4.5 Pulling Out of Small Molecule API Manufacturing
4.4.6 Expanding through New Services
4.4.7 Boehringer Ingelheim Biopharmaceuticals: Opportunities for Growth 2015-2025
4.4.8 Boehringer Ingelheim: Revenue Forecast 2015-2025
4.5 Fareva
4.5.1 Fareva Has 35 Years’ Manufacturing Experience
4.5.2 Revenue Growth through Acquisitions: 2010-2014
4.5.3 Fareva SWOT Analysis: 2015
4.5.4 Fareva Revenue Forecast: 2015-2025
4.6 Aenova Group
4.6.1 Acquisition of Haupt Creates European CMO Giant
4.6.2 Aenova’s Ever Expanding Manufacturing Capacity
4.6.3 Aenova’s Revenue 2010-2014: Organic Growth and Acquisitions
4.6.4 Aenova’s Competitive Position in the Contract Manufacturing Market: SWOT Analysis 2015
4.6.5 Becoming a Leading Contract Manufacturer: Aenova Revenue Forecast 2015-2025
4.7 Famar
4.7.1 Famar Is an Expert in Lyophilisation
4.7.2 Sustained Growth in Famar’s Revenue: 2010-2014
4.7.3 Expanding European Operations
4.7.4 Further Site Acquisitions Are an Opportunity for Growth 2015-2025
4.7.5 How Will Famar Perform 2015-2025?
4.8 Vetter Pharmaceutical
4.8.1 Vetter is an Injectable Manufacturing Specialist
4.8.2 Rapidly Growing Revenue in the US and Germany: 2010-2014
4.8.3 Services, Collaborations and Differentiating Factors
4.8.4 Expanding Services in US and Asia
4.8.5 Biologics Are an Opportunity for Growth for Vetter 2015-2025
4.8.6 Vetter Outlook: Revenue Forecast 2015-2025
4.9 Almac Group
4.9.1 Almac’s Manufacturing Services
4.9.2 Almac Outpaces the Market: 2011-2014
4.9.3 Almac Adding Capacity Globally
4.9.4 New Services Added 2012-2015
4.9.5 Almac Group: Contract Manufacturing Market Outlook 2015-2025
4.9.6 How Will Almac Group Perform 2015-2025?
4.10 Delpharm
4.10.1 Finished Dosage Form Manufacturing for Developed Markets
4.10.2 Delpharm: Rapid Revenue Growth Via Acquisitions, 2010-2014
4.10.3 Delpharm: Outlook and Prospects for Growth 2015-2025
4.10.4 Generics Will Drive Revenue Growth for Delpharm 2015-2025
4.11 Siegfried
4.11.1 Siegfried’s Acquisitions, 2010-2014
4.11.2 Expanding Siegfried’s Manufacturing Footprint Globally
4.11.3 Expanding High Potency API Capabilities
4.11.4 Siegfried: Financial Performance 2010-2014
4.11.5 Siegfried’s Characteristics within the Contract Manufacturing Market: SWOT Analysis 2015
4.11.6 Continued Revenue Growth for Siegfried 2015-2025
4.12 Corden Pharmaceutical
4.12.1 CordenPharma Service Division
4.12.2 CordenPharma Emerging in the API Market
4.12.3 Investments in Highly Potent Capabilities
4.12.4 CordenPharma: SWOT Analysis 2015-2025
4.13 Recipharm
4.13.1 Contract Development and Manufacturing Services
4.13.2 Recipharm: Financial Performance 2010-2014
4.13.3 Recipharm Invests in Facility Expansion
4.13.4 Recipharm Growing in Development & Technology Market through Acquisitions
4.13.5 Recipharm: Opportunities for Growth 2015-2025
4.13.6 Outlook for Recipharm: Revenue Forecast 2015-2025
4.14 Aesica Pharmaceuticals
4.14.1 Aesica Manufactures APIs and Finished Dosage Forms
4.14.2 Acquisitions Drive Revenue Growth but Operational Margins Have Declined, 2010-2014
4.14.3 Partnering with Academia for Innovative Solutions
4.14.4 Growth through Acquisitions and Internal Expansion
4.14.5 Aesica: Opportunities for Expansion 2015-2025
4.14.6 Forecast Aesica Financial Performance, 2015-2025

5. Leading Japanese Pharma Contract Manufacturing Organisations
5.1 Nipro Corporation: Japan’s Leading CMO
5.1.1 Nipro Pharmaceutical Contract Manufacturing Capabilities
5.1.2 Nipro: Decline in Revenue But Increasing Operating Profits 2010-2014
5.1.3 Biosimilars and Anti-Cancer Drugs Are Opportunities for Future Growth: SWOT Analysis 2015
5.1.4 Nipro Revenue and Profitability Forecast 2015-2025
5.2 Daito Pharmaceutical
5.2.1 Daito Has a Portfolio of More than 30 APIs
5.2.2 Rapid Growth in Revenue and Operational Profit: Daito Financial Performance 2010-2014
5.2.3 Daito Is Well-Placed for Asian Market Growth – SWOT Analysis 2015-2025
5.2.4 Sustained Growth in Revenue and Operating Profit for Daito, 2015-2025

6. Leading Developed-Market API Specialists
6.1 Teva API
6.1.1 API Manufacturing Services
6.1.2 Teva API: Financial Performance 2010-2014
6.1.3 Building a Footprint in Mexico, India and China
6.1.4 Teva API: SWOT Analysis 2015
6.1.5 Outlook for Teva API: Revenue Forecast 2015-2025
6.2 Esteve Química
6.2.1 Esteve Química Manufactures APIs for Developed and Emerging Markets
6.2.2 Expanding in The US, 2015
6.2.3 Esteve Química: SWOT Analysis 2015-2025
6.3 Euticals
6.3.1 Euticals Manufactures More than 200 APIs
6.3.2 Acquisitions Drive Growth 2010-2014
6.3.3 Adding Capacity for Finished Dosage Forms
6.3.4 Asian Expansion Is an Opportunity for Growth 2015-2025
6.3.5 Euticals: Revenue Forecast 2015-2025

7. Leading Chinese Pharmaceutical Contract Manufacturers
7.1 Zhejiang Hisun Pharmaceutical
7.1.1 API Manufacturing for Markets Worldwide
7.1.2 Zhejiang Hisun’s Rapid Growth in API Revenue Grows, 2010-2014
7.1.3 Moving Into International Drug Marketing
7.1.4 Zhejiang Hisun: Opportunities for Growth 2015-2025
7.1.5 Zhejiang Hisun: Strong API Revenue Growth 2015-2025
7.2 Zhejiang Huahai Pharmaceuticals
7.2.1 Zhejiang Huahai Is a Market Leader Within The Antihypertensive API Market
7.2.2 Zhejiang Huahai: Contract Manufacturing Performance 2010-2014
7.2.3 Expanding in the US Generic Drugs Market
7.2.4 Zhejiang Huahai: SWOT Analysis, 2015
7.2.5 Zhejiang Huahai: Revenue Forecast, 2015-2025
7.3 Shandong Xinhua Pharmaceutical
7.3.1 Experience in APIs and Finished Dosage Forms
7.3.2 Shandong Xinhua: Strong Revenue Growth 2010-2014
7.3.3 Growing through Joint Ventures
7.3.4 Looking to Expand in the US and EU 2015-2025
7.3.5 Shandong Xinhua Pharmaceutical: Revenue Forecast 2015-2025

8. Leading Indian Pharmaceutical Contract Manufacturers
8.1 Aurobindo Pharma
8.1.1 API Manufacturing Services
8.1.2 Aurobindo Pharma: Steady Revenue Growth 2010-2014
8.1.3 Aurobindo Expanding Outside of Antibacterials
8.1.4 Aurobindo: Opportunities for Expansion 2015-2025
8.1.5 How Will Aurobindo’s Contract Manufacturing Division Perform 2015-2025?
8.2 Divis Laboratories
8.2.1 Divis Laboratories and the Contract Manufacturing Industry
8.2.2 Divis Laboratories: A Rapidly Growing CMO, 2010-2014
8.2.3 Divis Laboratories: API Manufacturing Outlook 2015-2025
8.2.4 Divis Laboratories: API Manufacturing Revenue Forecast, 2015-2025
8.3 Dr. Reddy’s Laboratories
8.3.1 API and FDF Manufacturing Services
8.3.2 Dr. Reddy’s PSAI: Strong Revenue Growth 2010-2014
8.3.3 Advancing in Complex Drug Manufacturing
8.3.4 Expanding in the European Manufacturing Market
8.3.5 Dr. Reddy’s PSAI Division: Revenue Forecast 2015-2025

9. Research Interviews from Our Industry Survey
9.1 Dr Michael Quirmbach, Vice President, Global Sales & Marketing, CPI, Corden Pharma
9.2 Mrs Marianne Spaene, Executive Vice President, Global Head Business Development, Sales and Marketing, Siegfried
9.3 Dr Prabuddha Kundu, Cofounder & Executive Director, PREMAS Biotech

10. Conclusions of the Study
10.1 What Has Driven Growth for CMO Market Leaders in Recent Years?
10.2 Strategies for Growth: Prospects For Leading CMOs, 2015-2025
10.3 High Demand for Biopharmaceutical Manufacturing Services
10.4 Investing in Novel Technologies
10.5 Outlook for API Manufacturers


【レポート販売概要】

■ タイトル:世界のトップ30医薬品製造受託機関(CMO)
■ 英文:Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025
■ 発行日:2015年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN5100108
■ 調査対象地域:グローバル
  • 世界の金融業界におけるソフトウェア・テスト・サービス市場(2012-2016)
    TechNavio's analysts forecast the Global Software Testing Services market in BFSI sector to grow at a CAGR of 6.91 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce operational time and cost. The Global Software Testing Services market in BFSI sector has also been witnessing a shift from on-premise software testing to cloud-based sof …
  • 世界のVoIP市場予測:モバイル(mVoIP) vs.スタティックVoIP
    Since 2011, the VoIP market has changed drastically due to the introduction of highly innovative and effective mVoIP applications. Thanks to these, the global VoIP market has seen a radical increase in the number of subscriptions, especially since 2011 when various applications were commercially launched in the APAC region. However, the drastic increase on the number of VoIP subscriptions brought …
  • 世界の軍用レーダ市場動向2013-2023:市場のSWOT分析
    This SWOT analysis of Military Radar market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military Radar Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI strictly follows …
  • 装甲車両及びMRO(整備・修理・オーバーホール)の世界市場
    Summary The Global Armored Vehicles and MRO Market 2015-2025 report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global armored vehicles and MRO market is …
  • 電気自動車向け電磁誘導方式ワイヤレス充電システムの世界市場
    About Automotive Inductive Wireless Charging Systems Electric vehicles are gaining importance in modern times because of the rise in global fuel prices and alarming levels of air pollution. There is widespread concern about the negative effects of global warming. In such a scenario the rapid adoption of electric vehicles is seen as the most viable solution. The time taken to charge electric vehicl …
  • グリチルリチン酸モノアンモニウムの世界市場2015
    Monoammonium Glycyrrhizinate (CAS 53956-04-0) Market Research Report 2015 aims at providing comprehensive data on Monoammonium Glycyrrhizinate market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Monoammonium Glycyrrhizinate description, covers its application areas, manufacturing methods, patterns. It captures Monoammonium Glycyrrhizinate market tre …
  • Apache Corporation:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013
    Apache Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Apache Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
  • 世界の電気外科デバイス市場2015
    The Global Electrosurgical Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Electrosurgical Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Electrosurgical Devices market analysis is provided for the international markets includin …
  • 世界のミサイル及びミサイル防衛システムの市場動向2013-2023:主な開発プロジェクト
    This report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Missiles and Missile Defense Systems. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
  • 陰イオン界面活性剤の世界市場予測(~2022年)
    The anionic surfactants market was estimated at USD 16.36 Billion and is projected to reach USD 20.10 Billion by 2022, at a CAGR of 4.2% from 2017 to 2022. The market is expected to witness high growth in several growing economies of Asia Pacific and the Middle East & Africa owing to the increasing spending power, growth in the infrastructure industry, and growth in the manufacture of detergents a …
  • 世界のワッシャー液市場2015
    Global Washer Fluid Industry 2015 Market Research Reports is a professional and in-depth study on the current state of the Washer Fluid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Washer Fluid market analysis is provided for the international markets including development trends, competitive l …
  • Eスポーツの世界市場
    ABSTRACTAbout e-Sports The popularity of e-sports is increasing with the rising number of viewers. E-sports create an environment where viewers can experience playing the game. E-sports on a large scale is considered to be one of the most popular sports entertainment events in the world. On the global scenario, e-sports is a rapidly growing market and is likely to grow at a CAGR of 32.28%. In 2016 …
  • 医療用X線発生器の世界市場分析:製品別(固定式、ポータブル)、用途別(心臓血管、呼吸器、マンモグラフィー、整形外科、歯科)、セグメント予測
    The global medical X-ray generator market is expected to reach USD 2.07 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented shift in lifestyle associated habits coupled with increasing prevalence chronic diseases, is responsible for the rise in demand for accurate diagnostic tools, which is presumed to bolster the market growth. In addition, global geriatric p …
  • 世界のウエアラブル技術市場:フィットネス、mヘルス、拡張現実、カメラ、e-テキスタイル
    Wearable technology is the buzzword of 2014. A market that has existed for decades, the supporting technologies and public interest are finally sufficient for it to flourish. In an environment heading towards a connected homes paradigm, the next step in our technological evolution is bringing control closer than arm’s reach. Wearables dominated 2014’s CES, with many major OEMs moving into their se …
  • 世界における小型自動車用OE(メーカー純正部品)コネクティビティ(ネットワーク接続)市場動向と予測(~2029)
    This latest just-auto report edition offers a global review of the OE connected vehicle sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE connected vehicle market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。